Pfizer Europe MA EEIG
- J02 - Antimicóticos de uso sistémico
- VFEND film-coated tablet 200 mg
- VFEND film-coated tablet 50 mg
- VFEND powder for oral suspension 40 mg/ml
- VFEND powder for solution for infusion 200 mg
- L01 - Antineoplásicos
- TALZENNA capsule, hard 0.25 mg
- TALZENNA capsule, hard 1 mg
- VIZIMPRO film-coated tablet 15 mg
- VIZIMPRO film-coated tablet 30 mg
- VIZIMPRO film-coated tablet 45 mg
- XALKORI capsule, hard 200 mg
- XALKORI capsule, hard 250 mg
- ZIRABEV concentrate for solution for infusion 100 mg/4 ml
- L04 - Inmunosupresores
- XELJANZ film-coated tablet 10 mg
- XELJANZ film-coated tablet 5 mg
- XELJANZ oral solution
- XELJANZ prolonged-release tablet 11 mg
- M05 - Preparados para el tratamiento de enfermedades óseas
- ZOLEDRONIC ACID HOSPIRA concentrate for solution for infusion 4 mg/5 ml
- ZOLEDRONIC ACID HOSPIRA solution for infusion 4 mg/100 ml
- ZOLEDRONIC ACID HOSPIRA solution for infusion 5 mg/100 ml